Emerging Technologies

Investigations sponsored by the ISS National Laboratory will be performed, including tissue chip investigations to study liver regeneration and the immune aging process.

The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.

The company announced its expansion into a Silicon Valley-based production facility to develop its collaborative robotic system.

Dr. Terri Shieh-Newton, intellectual property attorney, immunologist and member of the law firm Mintz, tells MobiHealthNews about ownership rights concerning AI.

Dr. Brian Anderson, MITRE’s chief digital health physician and Coalition for Health AI cofounder, says AI requires regulation. He discusses the blueprint CHI developed for bias-mitigation, transparency, governance and monitoring in AI.

The organizations will evaluate the potential of generative AI and cloud technology to improve healthcare.

The purchase comes on the heels of the surgical navigation platform's $82.5 million Series D raise in June.

The Frontier Model Forum will identify best practices for responsible AI development, including supporting the creation of applications geared toward early cancer detection.

Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.